Oncolytics Biotech Inc.ONCYNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P3
Near historical low
vs 2Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -24.62% |
| Q2 2025 | 1.38% |
| Q1 2025 | -2.40% |
| Q4 2024 | -16.80% |
| Q3 2024 | -24.34% |
| Q2 2024 | -7.72% |
| Q1 2024 | -10.48% |
| Q4 2023 | -15.77% |
| Q3 2023 | 44.18% |
| Q2 2023 | -9.52% |
| Q1 2023 | -5.37% |
| Q4 2022 | -4.17% |
| Q3 2022 | -3.18% |
| Q2 2022 | -9.47% |
| Q1 2022 | -3.12% |
| Q4 2021 | -12.76% |
| Q3 2021 | -6.60% |
| Q2 2021 | 3.93% |
| Q1 2021 | 57.75% |
| Q4 2020 | 9.94% |
| Q3 2020 | -9.72% |
| Q2 2020 | 0.15% |
| Q1 2020 | 75.77% |
| Q4 2019 | 20.71% |
| Q3 2019 | 6.42% |
| Q2 2019 | -7.04% |
| Q1 2019 | 10.74% |
| Q4 2018 | -18.10% |
| Q3 2018 | -12.29% |
| Q2 2018 | 46.48% |
| Q1 2018 | -22.17% |
| Q4 2017 | 22.24% |
| Q3 2017 | -15.53% |
| Q2 2017 | 65.47% |
| Q1 2017 | -28.02% |
| Q4 2016 | -19.95% |
| Q3 2016 | -13.71% |
| Q2 2016 | -7.19% |
| Q1 2016 | -15.93% |
| Q4 2015 | -11.67% |